FI924817A0 - Behandling av stoerd funktion av erektion - Google Patents

Behandling av stoerd funktion av erektion

Info

Publication number
FI924817A0
FI924817A0 FI924817A FI924817A FI924817A0 FI 924817 A0 FI924817 A0 FI 924817A0 FI 924817 A FI924817 A FI 924817A FI 924817 A FI924817 A FI 924817A FI 924817 A0 FI924817 A0 FI 924817A0
Authority
FI
Finland
Prior art keywords
agent
agents include
agents
stoerd
erektion
Prior art date
Application number
FI924817A
Other languages
English (en)
Other versions
FI104946B (fi
FI924817A (fi
Inventor
Virgil A Place
Robert M Gale
Randall G Berggren
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FI924817A0 publication Critical patent/FI924817A0/fi
Publication of FI924817A publication Critical patent/FI924817A/fi
Application granted granted Critical
Publication of FI104946B publication Critical patent/FI104946B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/41—Devices for promoting penis erection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/16—Male reproductive, genital organs
    • A61M2210/167—Penis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Nursing (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Reverberation, Karaoke And Other Acoustics (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
  • Biological Treatment Of Waste Water (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Steroid Compounds (AREA)
FI924817A 1990-04-25 1992-10-23 Laite aktiivisen aineen antamiseksi virtsaputkeen FI104946B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51439790A 1990-04-25 1990-04-25
US51439790 1990-04-25
US9102758 1991-04-22
PCT/US1991/002758 WO1991016021A1 (en) 1990-04-25 1991-04-22 Treatment of erectile dysfunction

Publications (3)

Publication Number Publication Date
FI924817A0 true FI924817A0 (fi) 1992-10-23
FI924817A FI924817A (fi) 1992-10-23
FI104946B FI104946B (fi) 2000-05-15

Family

ID=24046960

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924817A FI104946B (fi) 1990-04-25 1992-10-23 Laite aktiivisen aineen antamiseksi virtsaputkeen

Country Status (16)

Country Link
EP (1) EP0526566B1 (fi)
JP (1) JP3477197B2 (fi)
KR (1) KR0169950B1 (fi)
AT (1) ATE173603T1 (fi)
AU (1) AU655420B2 (fi)
CA (2) CA2040914C (fi)
DE (1) DE69130529T2 (fi)
DK (1) DK0526566T3 (fi)
ES (1) ES2124225T3 (fi)
FI (1) FI104946B (fi)
IE (1) IE81089B1 (fi)
NO (1) NO300083B1 (fi)
NZ (2) NZ237899A (fi)
PT (1) PT97441B (fi)
WO (1) WO1991016021A1 (fi)
ZA (1) ZA912984B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962528A (en) * 1991-07-03 1999-10-05 Scott; Nathan Earl Prostaglandin E2 /F2α combination for treating impotence
US6291528B1 (en) 1991-07-03 2001-09-18 Nathan Earl Scott Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal
US5981593A (en) * 1991-07-03 1999-11-09 Scott; Nathan Earl Prostaglandin E2 treatment of impotence
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
SK124397A3 (en) * 1995-03-14 1998-12-02 Vivus Inc Method and kit for preventing erectile dysfunction
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
US5855548A (en) * 1996-06-14 1999-01-05 Vivus, Incorporated Venous flow control element for maintaining penile erection
GR1002847B (el) 1997-05-06 1998-01-27 Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
US6037360A (en) * 1997-10-28 2000-03-14 Vivus, Incorporated Administration of 5-HT3 receptor antagonists to treat premature ejaculation
US5919474A (en) * 1997-10-28 1999-07-06 Vivus, Inc. Transurethral administration of vasoactive agents to treat peripheral vascular disease, related vascular diseases, and vascular impotence associated therewith
US6228864B1 (en) * 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
US5925629A (en) * 1997-10-28 1999-07-20 Vivus, Incorporated Transurethral administration of androgenic agents for the treatment of erectile dysfunction
CA2314369A1 (en) * 1997-12-18 1999-06-24 Nathan Earl Scott Prostaglandin e2/f2.alpha. combination for treating impotence and enhancing sexual arousal
ES2155740B1 (es) * 1998-03-31 2001-12-01 Vita Invest Sa Dispositivo intrauretral para el tratamiento de la disfuncion erectil.
CA2251255A1 (en) * 1998-10-20 2000-04-20 Mcgill University The use of dopaminergic agents in the management of sexual dysfunction
AU1414200A (en) * 1998-12-02 2000-06-19 Mochida Pharmaceutical Co., Ltd. Preparations for intraurethral administration
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
WO2000051978A1 (en) 1999-03-01 2000-09-08 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
US6323241B1 (en) 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US7105571B2 (en) 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6693135B2 (en) 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
GR1004266B (el) * 2001-04-30 2003-06-18 Ηλιας Κ. Παπαδοπουλος Φαρμακευτικο παρασκευασμα για την διαγνωση και θεραπεια της στυτικης δυσλειτουργιας
KR20140054312A (ko) 2007-02-12 2014-05-08 디엠아이 바이오사이언시스 인코포레이티드 조루 및 발기부전을 동시에 치료하는 방법
EP2486921A1 (en) 2007-02-12 2012-08-15 DMI Biosciences, Inc. Reducing Side Effects of Tramadol
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease
CA2973096A1 (en) 2015-01-06 2016-07-14 Cardiovascular Biotherapeutics, Inc. Angiogenic treatment of ischemic heart disease
WO2016133848A2 (en) * 2015-02-16 2016-08-25 Cardiovascular Biotherapeutics, Inc. Therapeutic angiogenesis for treating erectile conditions
US10653549B2 (en) * 2017-07-18 2020-05-19 Carl W. Lange, IV Topical medication method for erectile dysfunction
BR102019016950A2 (pt) * 2019-08-15 2021-02-23 Inst De Pesquisa Ensino Ciencia E Tecnologia Aplicada Inst Galzu forma de dosagem intrauretral de medicamento; e dispositivo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1897423A (en) * 1928-10-30 1933-02-14 Ferri Filiberto Device for preventing gonorrhea infection
US4829991A (en) * 1987-01-06 1989-05-16 Medical Engineering Corp. Method and device for stimulating an erection
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
IT1221826B (it) * 1988-06-08 1990-07-12 Medico Harvey Srl Centro Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
IL87055A (en) * 1988-07-08 1994-06-24 Illana Gozes Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
DE3943519A1 (de) * 1989-04-27 1991-01-17 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen

Also Published As

Publication number Publication date
IE911330A1 (en) 1991-11-06
EP0526566A1 (en) 1993-02-10
KR0169950B1 (ko) 1999-01-15
DK0526566T3 (da) 1999-08-09
PT97441A (pt) 1992-05-29
JPH05506800A (ja) 1993-10-07
AU7856391A (en) 1991-11-11
CA2040914A1 (en) 1991-10-26
ZA912984B (en) 1992-01-29
CA2352552C (en) 2008-12-02
WO1991016021A1 (en) 1991-10-31
CA2040914C (en) 2001-12-04
ES2124225T3 (es) 1999-02-01
EP0526566B1 (en) 1998-11-25
NO924032D0 (no) 1992-10-19
JP3477197B2 (ja) 2003-12-10
FI104946B (fi) 2000-05-15
DE69130529T2 (de) 1999-06-02
IE81089B1 (en) 2000-03-08
NZ270871A (en) 1999-05-28
KR930700048A (ko) 1993-03-13
FI924817A (fi) 1992-10-23
ATE173603T1 (de) 1998-12-15
NZ237899A (en) 1997-03-24
DE69130529D1 (de) 1999-01-07
PT97441B (pt) 1998-08-31
NO300083B1 (no) 1997-04-07
CA2352552A1 (en) 1991-10-26
AU655420B2 (en) 1994-12-22
NO924032L (no) 1992-10-26

Similar Documents

Publication Publication Date Title
FI924817A (fi) Behandling av stoerd funktion av erektion
SE8803087L (sv) Ett nytt saett foer behandling av erektil dysfunktion
PE20010924A1 (es) Compuestos inhibidores de fosfodiesterasa utiles para el tratamiento de la disfuncion sexual femenina
DK629189D0 (da) Indretning til brug ved urinal inkontinens
JP2003505345A5 (fi)
DE69230475T2 (de) Verzögerte Freigabe Matrix für Arzneimittel
LU91039I2 (fr) Proteq flu et ses dérivés pharmaceutiquement acceptables
ATE120648T1 (de) Schmerzstillendes und entzündungshemmendes pflaster.
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
DE69225701D1 (de) Entfernbares Pessar
MY106528A (en) Method of treating impotence.
IT1247678B (it) Metodo per la cura dell'impotenza erettiva maschile
ZA969351B (en) Organic compositions
BE894860A (fr) Therapeutique adjuvante par agent progestatif
DE69943219D1 (de) Antikörper verwiesene enzymprodrugtherapie mit glukuronidase
Zufferey Risques vrais et faux de la contraception locale: spermicides, diaphragme
SE8904384D0 (sv) Pharmaceutical composition
BR9609868A (pt) Conjugado sintético de uma proteína e uma pluralidade de epítopos para uso em medicina processos para evitar a rejeição de um xenoenxerto ou pelo menos reduzir a extensão ou taxa de rejeição para tratar uma doença e sangue removido de um doador de sangue aparelho sangue composição farmaceuticamente aceitável e uso de um conjugado
KR930700109A (ko) 신경 질환 치료용 4,4'-[9h-플루오렌-9-일리덴비스(메틸렌)]-비스피리미딘
IT1238674B (it) Formulazione combinata di cimetidina-pirenzepina per il trattamento di ulcere ed erosioni peptiche
RU99103105A (ru) Способ лечения вторичной глаукомы
UA41462C2 (uk) Спосіб лікування гострого пієлонефриту
RU93010041A (ru) Способ профилактики послеродовых заболеваний и повышения оплодотворяемости у коров
DK336088A (da) Antitumormiddel opnaaet ved mikrobiel stereoselektiv reduktion af 4'-deoxy-4'-ioddoxorubicin

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: VIVUS, INC.